Effect of 2 vs 3 Doses of COVID-19 Vaccine in Patients With Inflammatory Bowel Disease: A Population-based Propensity Matched Analysis.

Aakash Desai Parakkal Deepak Raymond K CrossJulie MuroneFrancis A FarrayeRyan C UngaroGursimran S Kochhar

Published in: Inflammatory bowel diseases (2022)

Vaccinated patients with IBD had a lower risk of severe COVID-19 outcomes compared with unvaccinated patients. A third dose of COVID-19 vaccine compared with 2 doses decreases the risk of hospitalization but not breakthrough infection in patients with IBD.

Keyphrases

coronavirus disease
sars cov
patients with inflammatory bowel disease
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
respiratory syndrome coronavirus
type diabetes
metabolic syndrome
skeletal muscle
insulin resistance
drug induced